| 000 | 01462 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517221959.0 | ||
| 264 | 0 | _c20190128 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1475-2840 | ||
| 024 | 7 |
_a10.1186/s12933-018-0722-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhuang, Xiao-Dong | |
| 245 | 0 | 0 |
_aComparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials. _h[electronic resource] |
| 260 |
_bCardiovascular diabetology _c06 2018 |
||
| 300 |
_a79 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 | _aProtective Factors |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHe, Xin | |
| 700 | 1 | _aYang, Da-Ya | |
| 700 | 1 | _aGuo, Yue | |
| 700 | 1 | _aHe, Jian-Gui | |
| 700 | 1 | _aXiao, Hai-Peng | |
| 700 | 1 | _aLiao, Xin-Xue | |
| 773 | 0 |
_tCardiovascular diabetology _gvol. 17 _gno. 1 _gp. 79 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12933-018-0722-z _zAvailable from publisher's website |
| 999 |
_c28500009 _d28500009 |
||